Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6318302 | 0.93 | RORC (0.39) | — | |
| SCHEMBL6318307 | 0.93 | RORC (0.39) | — | |
| SCHEMBL6322629 | 0.90 | ACKR3 (0.40) | — | |
| SCHEMBL6322627 | 0.90 | ACKR3 (0.40) | — | |
| SCHEMBL6317327 | 0.90 | ALDH1A1 (0.38) | — | |
| SCHEMBL6317324 | 0.90 | ALDH1A1 (0.38) | — | |
| SCHEMBL6316449 | 0.89 | TP53 (0.38) | KMT2A | |
| SCHEMBL6316454 | 0.89 | TP53 (0.38) | KMT2A | |
| SCHEMBL6317122 | 0.88 | MEN1 (0.38) | MEN1KMT2A | |
| SCHEMBL6315666 | 0.88 | CYP3A4 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6887877-B2 | Compounds and methods for the treatment or prevention of Flavivirus infections | VIROCHEM PHARMA INC. (CA) | 2005-05-03 | — | — | US | claimed |
| US-20030229053-A1 | Compounds and methods for the treatment or prevention of flavivirus infections | SHIRE BIOCHEM INC. (CA) | 2003-12-11 | — | — | US | claimed |
| EP-4641693-A1 | POLYIMIDE COMPOUND, NEGATIVE ELECTRODE MATERIAL FOR LITHIUM ION SECONDARY BATTERIES THAT USES SAID POLYIMIDE COMPOUND, NEGATIVE ELECTRODE FOR LITHIUM ION SECONDARY BATTERIES, AND LITHIUM ION SECONDARY BATTERY | Wingo Technology Co., Ltd. (JP) | 2025-10-29 | — | — | EP | disclosed |
| US-12269949-B2 | Polyimide compound and molded article comprising the polyimide compound | WINGO TECHNOLOGY CO., LTD. (JP) | 2025-04-08 | — | — | US | disclosed |
| US-20240274820-A1 | POLYIMIDE COMPOUND, AND ANODE MATERIAL FOR LITHIUM-ION BATTERY USING THE SAME, ANODE FOR LITHIUM-ION BATTERY AND LITHIUM-ION BATTERY | WINGO TECHNOLOGY CO., LTD. (JP) | 2024-08-15 | — | — | US | disclosed |
| WO-2024135665-A1 | POLYIMIDE COMPOUND, NEGATIVE ELECTRODE MATERIAL FOR LITHIUM ION SECONDARY BATTERIES THAT USES SAID POLYIMIDE COMPOUND, NEGATIVE ELECTRODE FOR LITHIUM ION SECONDARY BATTERIES, AND LITHIUM ION SECONDARY BATTERY | ウィンゴーテクノロジー株式会社 | 2024-06-27 | — | — | WO | disclosed |
| EP-4318676-A1 | POLYIMIDE COMPOUND, NEGATIVE ELECTRODE MATERIAL FOR LITHIUM ION SECONDARY BATTERIES THAT USES SAID POLYIMIDE COMPOUND, NEGATIVE ELECTRODE FOR LITHIUM ION SECONDARY BATTERIES, AND LITHIUM ION SECONDARY BATTERY | Wingo Technology Co., Ltd. (JP) | 2024-02-07 | — | — | EP | disclosed |
| EP-3575281-B1 | DIAMINE COMPOUND, AND POLYIMIDE COMPOUND AND MOLDED ARTICLE IN WHICH SAID DIAMINE COMPOUND IS USED | WINGO TECH CO LTD (JP) | 2023-08-23 | — | — | EP | disclosed |
| WO-2022202701-A1 | POLYIMIDE COMPOUND, NEGATIVE ELECTRODE MATERIAL FOR LITHIUM ION SECONDARY BATTERIES THAT USES SAID POLYIMIDE COMPOUND, NEGATIVE ELECTRODE FOR LITHIUM ION SECONDARY BATTERIES, AND LITHIUM ION SECONDARY BATTERY | ウィンゴーテクノロジー株式会社 | 2022-09-29 | — | — | WO | disclosed |
| US-20220162445-A1 | POLYIMIDE COMPOUND AND MOLDED ARTICLE COMPRISING THE POLYIMIDE COMPOUND | WINGO TECHNOLOGY CO., LTD. (JP) | 2022-05-26 | — | — | US | disclosed |
| US-20150368509-A1 | POLYAMINES HAVING SECONDARY ALIPHATIC AMINO GROUPS | SIKA TECHNOLOGY AG (CH) | 2015-12-24 | — | — | US | disclosed |
| US-20130261270-A1 | POLYAMINES HAVING SECONDARY ALIPHATIC AMINO GROUPS | SIKA TECHNOLOGY AG (CH) | 2013-10-03 | — | — | US | disclosed |
| US-6939939-B2 | Polyurea/urethane optical material and method for making it | YOUNGER MFG. (US) | 2005-09-06 | — | — | US | disclosed |
| US-6887877-B2 | Compounds and methods for the treatment or prevention of Flavivirus infections | VIROCHEM PHARMA INC. (CA) | 2005-05-03 | — | — | US | disclosed |
| US-20050085617-A1 | Polyurea/urethane optical material and method for making it | YOUNGER MFG. CO. DBA YOUNGER OPTICS | 2005-04-21 | — | — | US | disclosed |
| US-20030229053-A1 | Compounds and methods for the treatment or prevention of flavivirus infections | SHIRE BIOCHEM INC. (CA) | 2003-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030229053-A1 | Compounds and methods for the treatment or prevention of flavivirus infections | HAVCR2, ZC3HAV1, MAVS | MEN1 2490/4885KMT2A 3263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.